The Blood Grouping Reagents Market in China has shown significant growth over the years, starting from a value of $133.7 million in 2012 and reaching $339.23 million in 2022. The market saw substantial year-on-year growth variations in the earlier years, particularly a notable spike of 50.8% in 2015. However, the past few years (2019-2022) have shown more stable and moderate growth, with year-on-year variations averaging around 4-5%. The CAGR for the last 5 years stands at 6.86%, indicating a steady growth trend.
Looking ahead, as of 2024, the market continues to be poised for further growth, driven by increased demand for blood transfusions, advancements in reagent technology, and expanded healthcare infrastructure. Policymakers and industry stakeholders should keep an eye on regulatory changes, technological advancements in automated blood grouping, and potential market disruptions due to global economic conditions, as these will significantly impact future market dynamics.
How does China rank in Blood Grouping Reagents Market Size Value?
| # | 16 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 352,470,000 | 2023 | +3.9% | +3.83% | |
| 2 | 2 United Kingdom | 110,710,000 | 2023 | +1.38% | +3.83% | View data |
| 3 | 3 Spain | 103,550,000 | 2023 | +3.37% | +4.68% | View data |
| 4 | 4 Italy | 95,043,000 | 2023 | +1.51% | +1.53% | View data |
| 5 | 5 Brazil | 35,183,000 | 2023 | -3.18% | -3.78% | View data |
